News
Studies Assess PET Scans as Tool for Guiding Therapy in Lymphoma
Though much of the lymphoma research presented at the Annual Meeting of the American Society of Hematology (ASH) in December 2014 focused on the growing number of novel therapies for this disease, a subset of presentations focused on the impact…
Patients with HIV-Related Lymphoma Can Successfully Undergo Autologous Stem-Cell Transplant
Double Hit Lymphoma Studies Hot Topic at 2014 ASH Annual Meeting
Double hit lymphoma (DHL) describes patients whose lymphoma tumors exhibit mutations on two significant genes, where most lymphoma patients have a mutation on only one. Currently found primarily in diffuse large B-cell lymphoma (DLBCL), DHL patients often respond poorly to…
ASH 2014 Features Promising New Treatments for Hodgkin Lymphoma
Among the many exciting clinical trials results presented at the Annual Meeting of the American Society of Hematology (ASH) in December 2014, were three significant studies for Hodgkin Lymphoma (HL) patients. The studies, which included early stage studies of two…